Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT/AYVAKYT (avapritinib) Full Year Revenue GuidancePR Newswire • about 6 hours ago
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT/AYVAKYT (avapritinib) Full Year Revenue Guidance Blueprint Medicines Reports Strong First Quarter 2024 Results and...
Share to Feed
Latest Ratings for BPMC
DateFirmActionFromTo Mar 2022StifelMaintainsBuy Mar 2022CitigroupInitiates Coverage OnNeutral Feb 2022SVB LeerinkDowngradesOutperformMarket Perform
View More Analyst...
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 PR Newswire...
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics Blueprint Medicines to Host Webcast and Conference Call Highlighting...
Shares of Blueprint Medicines Co. (NASDAQ:BPMC - Get Free Report) have earned an average rating of "Moderate Buy" from the fourteen brokerages that are covering the company, MarketBeat.com reports...
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass...
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Blueprint Medicines Corp (BPMC) was identified as having a larger market cap than the smaller end of the...
Blueprint Medicines Co. (NASDAQ:BPMC Get Free Report) Director Jeffrey W. Albers sold 11,033 shares of the stock in a transaction on Thursday, March 7th. The shares were sold at an average...
Blueprint Medicines Co. (NASDAQ:BPMC Get Free Report) Director Jeffrey W. Albers sold 11,033 shares of the firms stock in a transaction dated Thursday, March 7th. The shares were sold...
This price move could be a signal that BPMC may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...